Real-world experience with calcitonin gene-related peptide-targeted antibodies for migraine prevention: a retrospective observational cohort study at two Japanese headache centers

被引:0
|
作者
Mamoru Shibata
Kazuki Fujita
Eri Hoshino
Kazushi Minami
Kenzo Koizumi
Satoshi Okada
Fumihiko Sakai
机构
[1] Tokyo Dental College Ichikawa General Hospital,Department of Neurology
[2] Saitama International Headache Center,undefined
[3] Saitama Neuropsychiatric Institute,undefined
[4] Saitama International Headache Center,undefined
来源
BMC Neurology | / 24卷
关键词
Migraine; Calcitonin gene-related peptide (CGRP); Monoclonal antibody; Real world; Headache Impact Test-6 (HIT-6); Japanese;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies
    Ferreira, Vinicius L.
    Mainka, Felipe F.
    Wiens, Astrid
    Pontarolo, Roberto
    CLINICAL DRUG INVESTIGATION, 2023, 43 (09) : 669 - 680
  • [22] Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies
    Vinicius L. Ferreira
    Felipe F. Mainka
    Astrid Wiens
    Roberto Pontarolo
    Clinical Drug Investigation, 2023, 43 : 669 - 680
  • [23] Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodies
    Schwedt, Todd J.
    Lee, Jae
    Knievel, Kerry
    McVige, Jennifer
    Wang, Weiying
    Wu, Zheng
    Gillard, Patrick
    Shah, Darshini
    Blumenfeld, Andrew M.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (10): : 1119 - 1128
  • [24] Comparative effectiveness and tolerability of calcitonin gene-related peptide (CGRP) monoclonal antibodies and onabotulinumtoxinA in chronic migraine: A multicenter, real-world study in Taiwan
    Wang, Yen-Feng
    Yang, Fu-Chi
    Chen, Lu-An
    Chang, Ting-Yu
    Su, Hui-Chen
    Yang, Chun-Pai
    Tu, Yi-Hsien
    Tzeng, Yi-Shiang
    Chen, Shih-Pin
    Fuh, Jong-Ling
    Lai, Kuan-Lin
    Ling, Yu-Hsiang
    Chen, Wei-Ta
    Wang, Shuu-Jiun
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (09)
  • [25] Use of a second or third monoclonal antibody to calcitonin gene-related peptide in chronic migraine: real-world experience from a tertiary headache centre in Glasgow, Scotland
    Lowe, Michael
    Stobo, Laura
    Benchiheub, Anissa
    Gorrie, George
    Miller, Sarah
    Tyagi, Alok
    Dani, Krishna
    CEPHALALGIA, 2023, 43 (1supp)
  • [26] Adherence and persistence associated with calcitonin gene-related peptide monoclonal antibodies compared to non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine
    Foster, S. A.
    Manjelievskaia, J.
    Ford, J. H.
    Ye, W.
    Perry, A.
    Schuh, K.
    Wenzel, R.
    HEADACHE, 2021, 61 : 54 - 54
  • [27] Switching associated with initiation of calcitonin gene-related peptide monoclonal antibodies versus non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine
    Foster, S. A.
    Manjelievskaia, J.
    Ford, J. H.
    Ye, W.
    Perry, A.
    Schuh, K.
    Wenzel, R.
    HEADACHE, 2021, 61 : 75 - 76
  • [28] Patient satisfaction with calcitonin gene-related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study
    Lopez-Bravo, Alba
    Minguez-Olaondo, Ane
    Nieves-Castellanos, Candela
    Ruibal-Salgado, Marta
    Sanchez-Mateos, Noemi Morollon
    Navarro-Perez, Maria Pilar
    Alpuente, Alicia
    Torres-Ferrus, Marta
    Garcia-Ull, Jesica
    Gago-Veiga, Ana
    Garcia-Azorin, David
    Gonzalez-Martinez, Alicia
    Sierra, Alvaro
    Santos-Lasaosa, Sonia
    HEADACHE, 2025,
  • [29] Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study
    De Matteis, Eleonora
    Caponnetto, Valeria
    Casalena, Alfonsina
    Frattale, Ilaria
    Gabriele, Amleto
    Affaitati, Giannapia
    Giamberardino, Maria Adele
    Maddestra, Maurizio
    Viola, Stefano
    Pistoia, Francesca
    Sacco, Simona
    Ornello, Raffaele
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [30] Are anti-calcitonin gene-related peptide monoclonal antibodies effective in treating migraine aura? A pilot prospective observational cohort study
    Simone Braca
    Angelo Miele
    Antonio Stornaiuolo
    Gennaro Cretella
    Roberto De Simone
    Cinzia Valeria Russo
    Neurological Sciences, 2024, 45 : 1655 - 1660